Insights

Expanding Market Presence RAFARM is actively expanding its exports worldwide, reaching over 60 countries, which indicates significant international sales potential and opportunities to introduce specialized pharmaceutical products into new markets.

Ongoing Product Development With over 100 active product licenses and the development of 10 new pharmaceutical products annually, there are continuous opportunities to collaborate on new formulations or expand existing product lines to meet emerging market needs.

Strategic Partnerships Recent collaborations with organizations such as Ophthalmology Times, Modern Retina, and Padagis LLC highlight RAFARM's openness to partnering, offering potential avenues to co-develop specialized ophthalmic and sterile pharmaceutical solutions.

Investment in Innovation The company invests 10% of its net turnover into R&D and is undertaking a €65 million investment program from 2021 to 2025, creating opportunities for suppliers and partners to integrate with their advanced research and manufacturing capabilities.

Focused Therapeutic Areas RAFARM's expertise in ophthalmic and injectable pharmaceutical products, combined with its ability to adapt quickly and prioritize time-to-market, makes it a valuable partner for businesses seeking specialized formulations in these high-demand segments.

Similar companies to RAFARM S.A.

RAFARM S.A. Tech Stack

RAFARM S.A. uses 8 technology products and services including Open Graph, WordPress, SQL, and more. Explore RAFARM S.A.'s tech stack below.

  • Open Graph
    Content Management System
  • WordPress
    Content Management System
  • SQL
    Database
  • Lightbox
    Javascript Libraries
  • jQuery Mobile
    Mobile Frameworks
  • PHP
    Programming Languages
  • Google Analytics
    Web Analytics
  • Contact Form 7
    Web Platform Extensions

RAFARM S.A.'s Email Address Formats

RAFARM S.A. uses at least 1 format(s):
RAFARM S.A. Email FormatsExamplePercentage
F.Last@rafarm.grJ.Doe@rafarm.gr
91%
FLast@rafarm.grJDoe@rafarm.gr
5%
First.Last@rafarm.grJohn.Doe@rafarm.gr
3%
L.First@rafarm.grD.John@rafarm.gr
1%

Frequently Asked Questions

Where is RAFARM S.A.'s headquarters located?

Minus sign iconPlus sign icon
RAFARM S.A.'s main headquarters is located at 10000 Greece Athens, Attikí Greece. The company has employees across 3 continents, including EuropeAsiaAfrica.

What is RAFARM S.A.'s phone number?

Minus sign iconPlus sign icon
You can contact RAFARM S.A.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is RAFARM S.A.'s official website and social media links?

Minus sign iconPlus sign icon
RAFARM S.A.'s official website is rafarm.gr and has social profiles on LinkedIn.

What is RAFARM S.A.'s NAICS code?

Minus sign iconPlus sign icon
RAFARM S.A.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does RAFARM S.A. have currently?

Minus sign iconPlus sign icon
As of March 2026, RAFARM S.A. has approximately 452 employees across 3 continents, including EuropeAsiaAfrica. Key team members include Cfo / Finance - Is - Purchasing Lead: J. P.Chief Scientific Officer: G. C.Chief Operating Officer: N. P.. Explore RAFARM S.A.'s employee directory with LeadIQ.

What industry does RAFARM S.A. belong to?

Minus sign iconPlus sign icon
RAFARM S.A. operates in the Pharmaceutical Manufacturing industry.

What technology does RAFARM S.A. use?

Minus sign iconPlus sign icon
RAFARM S.A.'s tech stack includes Open GraphWordPressSQLLightboxjQuery MobilePHPGoogle AnalyticsContact Form 7.

What is RAFARM S.A.'s email format?

Minus sign iconPlus sign icon
RAFARM S.A.'s email format typically follows the pattern of F.Last@rafarm.gr. Find more RAFARM S.A. email formats with LeadIQ.

When was RAFARM S.A. founded?

Minus sign iconPlus sign icon
RAFARM S.A. was founded in 1974.

RAFARM S.A.

Pharmaceutical ManufacturingAttikí, Greece201-500 Employees

RAFARM 
We evolve beyond the obvious; we make a positive impact on people’s lives and ensure a healthier future. 
 
How far can we get?
Well, we take a step forward, daily.
Every day we discover new paths
Every day we go beyond the obvious, we march ahead towards a healthier future.
 
We are RAFARM, innovation-driven, dynamically growing, and one of the largest Greek pharmaceutical companies with an outward-looking orientation.
 
We invest 10% of net turnover in Research and Development
>100 RAFARM development products
10 new products are being developed
every year by the R&D department
40 active pharmaceutical technology projects every year
1,100 active pharmaceutical licenses formulations 

We create new employment opportunities of high expertise
We expand our exports worldwide (>60 countries)
We have three state-of-the-art production units, new independent
Research Center and storage space, with a total area of 16,000 sq.m.
We are implementing one of the largest investment programs for years
2021-2025 in Greece, amounting to €65 million
 
We rapidly grow our commercial activity in the domestic market  and we are expanding our product portfolio.
 
At RAFARM, we are driven by knowledge; that’s why we are constantly developing thus enhancing our expertise in the development and production of ophthalmic and injectable pharmaceutical products.  

We achieve results that are beyond the obvious due to our team of highly knowledgeable R&D scientists, the cutting-edge technology we apply in production and our holistic approach to regulatory affairs.

We act with promptness and agility.  We adapt to the needs of the constantly developing pharmaceutical field making use of technology, our customer-oriented approach and primary focus on the individual. 

Why to partner with us? 
o   Enriched options of complex pharmaceutical products
o   Flexible business partnerships worldwide
o   R&D extensive expertise on sterile forms
o   Focus on time to market
o   Supplier reliability

Section iconCompany Overview

Headquarters
10000 Greece Athens, Attikí Greece
Phone number
Website
rafarm.gr
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1974
Employees
201-500

Section iconFunding & Financials

  • $10M$25M

    RAFARM S.A.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    RAFARM S.A.'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.